The MedicX Fund Limited Scrip Dividend Declaration (4768Q)
12 September 2017 - 6:01PM
UK Regulatory
TIDMMXF
RNS Number : 4768Q
The MedicX Fund Limited
12 September 2017
For immediate release
12 September 2017
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Scrip Dividend Declaration
MedicX Fund (LSE: MXF) announces that, pursuant to its scrip
dividend scheme (the "Scrip Dividend Alternative"), elections were
received in respect of 1.5 per cent. of the ordinary shares in
issue as at the record date of 18 August 2017. Electing
shareholders will receive ordinary shares of no par value in the
Company ("Shares") in lieu of receiving cash for the September 2017
dividend in respect of the quarter ended 30 June 2017. Accordingly,
109,895 Shares will be sold out of treasury by the Company on 28
September 2017 to shareholders who elected to participate in the
Scrip Dividend Alternative.
The Shares will rank pari passu with the existing ordinary
shares.
Following the transaction, the Company is expected to have
436,002,399 ordinary shares in issue, of which 7,362,255 will be
held in treasury and has 14,771,668 ordinary shares of no par value
remaining under its block listing facility. Accordingly the total
voting rights in issue will be 428,640,144.
Copies of the documents relating to the Scrip Dividend
Alternative are available for inspection through the National
Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Vicky Hayns
Information on MedicX Fund Limited
MedicX Fund Limited (the "Fund" or the "Company", or together
with its subsidiaries, the "Group") is the specialist primary care
infrastructure investor in modern, purpose-built primary healthcare
properties in the United Kingdom and Ireland, listed on the London
Stock Exchange, with a portfolio comprising 156 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1.1 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP7 billion of funds for more than 50,000 retail and institutional
investors as well as supplying energy to more than 100,000
customers
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DIVDLLBFDKFEBBK
(END) Dow Jones Newswires
September 12, 2017 04:01 ET (08:01 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024